Search

Your search keyword '"CARAI, ANDREA"' showing total 545 results

Search Constraints

Start Over You searched for: Author "CARAI, ANDREA" Remove constraint Author: "CARAI, ANDREA"
545 results on '"CARAI, ANDREA"'

Search Results

2. The coexistence of a BRCA2 germline and a DICER1 somatic variant in two first-degree cousins suggests their potential synergic effect

6. Patient‐ and xenograft‐derived organoids recapitulate pediatric brain tumor features and patient treatments

7. Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas

8. PATZ1-Rearranged Tumors of the Central Nervous System: Characterization of a Pediatric Series of Seven Cases

9. Robot-Assisted Endoscopy

10. Intracerebellar administration of the chemokine Cxcl3 reduces the volume of medulloblastoma lesions at an advanced stage by promoting the migration and differentiation of preneoplastic precursor cells.

11. MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression

12. Coexistence of a BRCA2 germline and a DICER1 somatic variant in two first- degree young cousins: a potential cooperative role in determining cancer susceptibility?

13. Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling

14. Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile.

15. Real-life experience with a “modified-MEMMAT” regimen for relapsed medulloblastoma

17. GD2-targeting CAR T-cell therapy for patients with GD2+ medulloblastoma

19. Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?

21. Gliomatosis cerebri in children:A poor prognostic phenotype of diffuse gliomas with a distinct molecul profile

22. Successful staged separation of total angular craniopagus.

23. Machine Learning Analysis in Diffusion Kurtosis Imaging for Discriminating Pediatric Posterior Fossa Tumors: A Repeatability and Accuracy Pilot Study.

28. Case Report: Remarkable breakthrough: successful treatment of a rare intracranial mesenchymal, FET::CREB fusion-positive tumor treated with patient-tailored multimodal therapy

29. PATZ1-rearranged tumors of the central nervous system: characterization of a pediatric series of seven cases

30. Operator perceived advantage of virtual surgical rehearsal in pediatric neurosurgical oncology: a preliminary experience

31. A systematic review of data sources for artificial intelligence applications in pediatric brain tumors in Europe: implications for bias and generalizability

32. Unraveling the impact of upfront chemotherapy and proton beam therapy on treatment outcome and follow-up in central nervous system germ cell tumors: a single center experience

33. Primary cerebral cystic echinococcosis in a child from Roman countryside: Source attribution and scoping review of cases from the literature

35. Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?

37. International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma

38. SHH medulloblastoma and very early onset of bowel polyps in a child with PTEN hamartoma tumor syndrome

39. High-Grade Gliomas and Cancer Predisposition Syndromes in children and adolescents: Unpacking the Impact through a Single-Center Analysis

40. Calcium phosphate and titanium cranioplasty after total angular craniopagus separation

41. HGG-17. SINGLE-CELL AND SPATIAL ANALYSES DECIPHER THE UNIQUE INVASIVE GROWTH PATTERN OF GLIOMATOSIS CEREBRI

44. Data from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

45. Supplementary Data from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

46. Supplementary Table S3 from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

47. Table S1 from Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma

48. Figure S1-S12 from Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma

49. Data from Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma

50. The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors

Catalog

Books, media, physical & digital resources